You searched for "blindness"
Highlights from The RCOphth Annual Congress 2023
Check in here for live updates and media from the RCOphth Annual Congress 2023 being held in Birmingham's ICC between 22-25 May.Supplements
Welcome to our supplements, please select a name and the issue will appear.Considerations in the management of retinal disorders
1 October 2017
| Rod McNeil
|
EYE - Vitreo-Retinal
Vision research presentations and publications explore practice considerations in the management of AMD and diabetic retinopathy. Over the past two decades in Europe there has been a decreasing prevalence of age-related macular degeneration (AMD) and an improvement in visual acuity...
Corporate M&A pace gathers momentum
1 October 2019
| Rod McNeil
|
AMD, Emergency Ophthalmology, Genetics, Ophthalmology, Optometry, EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...
What’s new in wet AMD papers?
1 December 2016
| Rod McNeil
|
EYE - Vitreo-Retinal
Paper presentations on neovascular (‘wet’) age-related macular degeneration (AMD) from the 16th European Society of Retina Specialists Congress, Copenhagen, September 2016, outline recent research directions evaluating the impact of vision loss on key health domains, patient preferences in the process...
Celebrating 225 years of seeing ability in parliament
This October, the House of Lords provided the venue for charity SeeAbility’s celebration of its 225th-year anniversary, with people it supports, colleagues, volunteers, funders and partners. They were joined by parliamentarians, including the Rt Hon Lord David Blunkett, who sponsored...Sensitive cilia – eyelashes in health and disease
5 October 2020
| Jonathan CP Roos, Rachna Murthy
|
Ophthalmology, Optometry, EYE - Cornea, EYE - Orbit, EYE - Oculoplastic
In health our eyelashes protect the eyes, but in disease they can disfigure, impair quality of life and threaten vision. In this review the authors discuss aspects of lashes that are relevant to all professionals working near the eyes and...
National sight loss charity calls for street credibility
Urgent action must be taken to improve street design and accessibility for blind and partially sighted pedestrians says the Royal National Institute of Blind People (RNIB) Scotland in their latest report, ‘Street Credibility’.Nanosecond laser cataract surgery
2 December 2019
| Ahmed Hamroush, Balasubramaniam Ilango
|
Ophthalmology, EYE - Cataract, EYE - Refractive
The authors review the evidence for nanosecond laser cataract surgery: is this the future? Cataract is a leading cause of visual impairment worldwide, and cataract surgery is one of the most successful and cost-effective healthcare interventions, with a great impact...
The original smooth operator: Sir Robin Millar
4 December 2023
| Peter Cackett
|
Genetics
As an early 80s kid, if you lacked sufficient pocket money, building a music collection entailed recording your favourite songs off the radio with a cassette deck and hoping the presenter didn’t interrupt at any point, with a finger hovering...
Typical or surprisingly uncharacteristic presentations of neuro-ophthalmic emergencies
Irrespective of geographical location or patient cohort, emergency departments are high risk locations capable of inspiring extreme anxiety and dread in patients and doctors alike. The stress multiplies when a walk-in or referred case is suspected of underlying neurological pathology....Addressing medical risk factors for diabetes and understanding the new systemic treatments
1 February 2014
| Samantha S Mann
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...